Published in Women's Health Weekly, September 7th, 2000
Wyeth-Ayerst Pharmaceuticals recently mailed letters to 9,100 Norplant providers and wholesalers asking that packages shipped beginning October 7, 1999, not be used until further testing can settle questions about the product's effectiveness, the Milwaukee Journal Sentinel newspaper reported on August 17, 2000.
"We recommend taking this precaution while we further evaluate the shelf-life stability of these lots of Norplant and any potential clinical relevance of these...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.